GR2003155Y - Εξοπλισμος για χορηγηση φαρμακων - Google Patents

Info

Publication number

GR2003155Y

GR2003155Y GR20190200094U GR20190200094U GR2003155Y GR 2003155 Y GR2003155 Y GR 2003155Y GR 20190200094 U GR20190200094 U GR 20190200094U GR 20190200094 U GR20190200094 U GR 20190200094U GR 2003155 Y GR2003155 Y GR 2003155Y

Authority

GR

Greece

Prior art keywords

video

drug delivery

delivery device

box

equipment according

Prior art date

2018-04-27

Links

• Espacenet
• Global Dossier
• Discuss

• 239000003814 drug Substances 0.000 title claims abstract description 21
• 230000000007 visual effect Effects 0.000 claims abstract description 10
• 238000012377 drug delivery Methods 0.000 claims description 122
• 238000013500 data storage Methods 0.000 claims description 14
• 229940079593 drug Drugs 0.000 claims description 10
• 102000002265 Human Growth Hormone Human genes 0.000 claims description 8
• 108010000521 Human Growth Hormone Proteins 0.000 claims description 8
• 239000000854 Human Growth Hormone Substances 0.000 claims description 8
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 8
• UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 4
• 229930182837 (R)-adrenaline Natural products 0.000 claims description 4
• 102000004877 Insulin Human genes 0.000 claims description 4
• 108090001061 Insulin Proteins 0.000 claims description 4
• 238000001647 drug administration Methods 0.000 claims description 4
• 230000002708 enhancing effect Effects 0.000 claims description 4
• 229960005139 epinephrine Drugs 0.000 claims description 4
• 230000010437 erythropoiesis Effects 0.000 claims description 4
• 229940125396 insulin Drugs 0.000 claims description 4
• 230000007246 mechanism Effects 0.000 claims description 4
• 230000037317 transdermal delivery Effects 0.000 claims description 3
• 239000013543 active substance Substances 0.000 claims 2
• 230000003247 decreasing effect Effects 0.000 abstract 1
• 238000011282 treatment Methods 0.000 description 5
• 230000001684 chronic effect Effects 0.000 description 4
• 238000001802 infusion Methods 0.000 description 4
• 239000004480 active ingredient Substances 0.000 description 3
• 229940090047 auto-injector Drugs 0.000 description 3
• 238000007391 self-medication Methods 0.000 description 3
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 208000030961 allergic reaction Diseases 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 230000003449 preventive effect Effects 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 229960005486 vaccine Drugs 0.000 description 2
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 229960003971 influenza vaccine Drugs 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 230000007257 malfunction Effects 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 231100000572 poisoning Toxicity 0.000 description 1
• 230000000607 poisoning effect Effects 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1